PHILIP SAMPSON: Open Payments
NPI 1508974213 · LIVINGSTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 20 payments from 9 companies in 2025. Trend: 2023 $970 · 2024 $1,249 · 2025 $575
Food & beverage: $475Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $310 |
| ABBVIE INC. | 4 | $91 |
| Ferring Pharmaceuticals Inc. | 3 | $54 |
| Astellas Pharma US Inc | 1 | $26 |
| Antares Pharma, Inc. | 1 | $23 |
| ACCORD HEALTHCARE, INC. | 1 | $22 |
| COLOPLAST CORP | 1 | $21 |
| Laborie Medical Technologies Corp. | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
Products named: ERLEADA, BOTOX, ADSTILADRIN, Xtandi, XYOSTED, Camcevi, Altis, Lumenis Pulse 120H.
Industry payments across CA — which companies pay providers there.
